Prostate Cancer UK has been shortlisted for two awards at the 2013 Chartered Institute of Public Relations (CIPR) Scotland PRide Awards.
Prostate Cancer UK is one of a handful of charities who have made it through to the final of the prestigious awards, and will compete against top PR agencies and national organisations for recognition of its outstanding work on behalf of men with the disease in Scotland.
Prostate Cancer UK has been shortlisted for two awards - Best Not-For-Profit Campaign, and Best Public Affairs Campaign - for its successful in-house campaign to get the life-enhancing and life-prolonging prostate cancer drug, abiraterone, approved on NHS Scotland. The news comes shortly after the charity's near miss at this year's SCVO Scottish Charity Awards and subsequent victory at the Communiqué Awards for the same campaign.
Head of Policy & Campaigns at Prostate Cancer UK, Drew Lindon, said: "We are delighted to have been shortlisted for two PRide Awards in recognition of our campaign to have abiraterone approved for use on the NHS. Men with prostate cancer were at the forefront of this successful campaign, so this is a fitting tribute to their tireless hard work and determination to ensure men across Scotland can get the best possible care - we could not have achieved this without our outstanding volunteers. The success of our campaign, and this recognition of it, marks an important milestone on our journey to ensure all men have access to the right treatments for prostate cancer in Scotland."
The CIPR PRide Awards recognise the outstanding talents and achievements of public relations and public affairs practitioners across the UK's regions and nations, and hold the reputation of being the most prestigious and rigorous awards of their kind. This year marks the tenth anniversary of the CIPR PRide awards, which will be held at The Grand Central Hotel in Glasgow.
CIPR President Sue Wolstenhome FCIPR, said: "The CIPR PRide Awards celebrate the very best in public relations across the UK. This year's entries were all of an incredibly high standard, highlighting the industry-leading work that is taking place. I would like to congratulate all of those who have been shortlisted for an award; their success demonstrates their exemplary achievements in such a thriving profession, and recognises the impact they have made."